Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with ...
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the U.S.
The evaluation committee considered evidence submitted by Norgine, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results